4D Molecular Therapeutics
FDMT
FDMT
111 hedge funds and large institutions have $892M invested in 4D Molecular Therapeutics in 2023 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 43 increasing their positions, 28 reducing their positions, and 19 closing their positions.
Holders
111
Holders Change
+1
Holders Change %
+0.91%
% of All Funds
1.63%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.03%
New
20
Increased
43
Reduced
28
Closed
19
Calls
$3.07M
Puts
$4.51M
Net Calls
-$1.44M
Net Calls Change
-$1.45M
Top Buyers
| 1 |
1
Morgan Stanley
New York
|
$63.6M |
| 2 |
2
Goldman Sachs
New York
|
$16.5M |
| 3 |
3
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
$9.87M |
| 4 |
VA
4
VR Adviser
New York
|
$69.4M |
| 5 |
IHAM
5
Integral Health Asset Management
New York
|
$7.6M |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
AWM
126
Affinity Wealth Management
Wilmington,
Delaware
| – | -$146K | -11,471 | Closed |
|
|
PMEF
127
Point72 Middle East FZE
Dubai,
United Arab Emirates
| – | -$144K | -11,304 | Closed |
|
|
VA
128
Vident Advisory
Alpharetta,
Georgia
| – | -$135K | -10,574 | Closed |
|
|
NFSG
129
Newbridge Financial Services Group
Boca Raton,
Florida
| – | -$382 | -30 | Closed |
|
130
Russell Investments Group
London,
United Kingdom
| – | -$204 | -16 | Closed |
|